Stock chart
Ticker: ALEC Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-05 2025-03-03 S Sale

GRASSO MARC

Chief Financial Officer

Officer
18,091 -5.5%
1.47
USD 26,547
18,091 -5.5% 1.47 USD 26,547
2025-03-05 2025-03-03 S Sale

Romano Gary

Chief Medical Officer

Officer
16,306 -4.7%
1.47
USD 23,927
16,306 -4.7% 1.47 USD 23,927
2025-03-05 2025-03-03 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
40,330 -1.6%
1.47
USD 59,176
40,330 -1.6% 1.47 USD 59,176
2025-03-05 2025-03-03 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
29,073 -5.1%
1.47
USD 42,662
29,073 -5.1% 1.47 USD 42,662
2024-12-03 2024-12-02 S Sale

GRASSO MARC

Chief Financial Officer

Officer
16,489 -4.7%
2.52
USD 41,542
16,489 -4.7% 2.52 USD 41,542
2024-12-03 2024-12-02 S Sale

Romano Gary

Chief Medical Officer

Officer
14,892 -4.1%
2.52
USD 37,519
14,892 -4.1% 2.52 USD 37,519
2024-12-03 2024-12-02 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
26,500 -4.5%
2.52
USD 66,764
26,500 -4.5% 2.52 USD 66,764
2024-12-03 2024-12-02 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
52,172 -2.0%
2.52
USD 131,442
52,172 -2.0% 2.52 USD 131,442
2024-09-04 2024-09-03 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
13,926 -4.6%
4.88
USD 67,981
13,926 -4.6% 4.88 USD 67,981
2024-09-04 2024-09-03 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
26,499 -1.3%
4.88
USD 129,387
26,499 -1.3% 4.88 USD 129,387
2024-09-04 2024-09-03 S Sale

Romano Gary

Chief Medical Officer

Officer
8,478 -4.5%
4.88
USD 41,385
8,478 -4.5% 4.88 USD 41,385
2024-09-04 2024-09-03 S Sale

GRASSO MARC

Chief Financial Officer

Officer
7,297 -5.3%
4.88
USD 35,620
7,297 -5.3% 4.88 USD 35,620
2024-08-23 2024-08-22 S Sale

SCHELLER RICHARD H

Non-Executive Director
44,250 -55.8%
5.16
USD 228,388
44,250 -55.8% 5.16 USD 228,388
2024-08-13 2024-08-12 PS Planned sale

Yaffe Kristine

Non-Executive Director
5,000 -6.9%
5.06
USD 25,309
5,000 -6.9% 5.06 USD 25,309
2024-08-13 2024-08-12 PS Planned sale

Hammond Paula

Non-Executive Director
10,500 -14.8%
5.06
USD 53,179
10,500 -14.8% 5.06 USD 53,179
2024-06-04 2024-06-03 S Sale

GRASSO MARC

Chief Financial Officer

Officer
6,920 -4.8%
4.80
USD 33,208
6,920 -4.8% 4.80 USD 33,208
2024-06-04 2024-06-03 S Sale

Romano Gary

Chief Medical Officer

Officer
8,040 -4.1%
4.80
USD 38,582
8,040 -4.1% 4.80 USD 38,582
2024-06-04 2024-06-03 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
13,206 -4.1%
4.80
USD 63,373
13,206 -4.1% 4.80 USD 63,373
2024-06-04 2024-06-03 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
25,135 -1.3%
4.80
USD 120,618
25,135 -1.3% 4.80 USD 120,618
2024-03-05 2024-03-04 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
10,169 -3.1%
6.92
USD 70,387
10,169 -3.1% 6.92 USD 70,387
2024-03-05 2024-03-04 S Sale

GRASSO MARC

Chief Financial Officer

Officer
5,716 -3.8%
6.92
USD 39,562
5,716 -3.8% 6.92 USD 39,562
2024-03-05 2024-03-04 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
18,837 -0.9%
6.92
USD 130,386
18,837 -0.9% 6.92 USD 130,386
2024-03-05 2024-03-04 S Sale

Romano Gary

Chief Medical Officer

Officer
6,001 -3.0%
6.92
USD 41,554
6,001 -3.0% 6.92 USD 41,554
2023-12-06 2023-12-04 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
23,831 -1.2%
5.56
USD 132,500
23,831 -1.2% 5.56 USD 132,500
2023-12-06 2023-12-04 S Sale

GRASSO MARC

Chief Financial Officer

Officer
4,574 -2.9%
5.56
USD 25,431
4,574 -2.9% 5.56 USD 25,431
2023-12-06 2023-12-04 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
12,519 -3.7%
5.56
USD 69,606
12,519 -3.7% 5.56 USD 69,606
2023-12-06 2023-12-04 S Sale

Romano Gary

Chief Medical Officer

Officer
5,035 -2.4%
5.56
USD 27,995
5,035 -2.4% 5.56 USD 27,995
2023-09-13 2023-09-11 S Sale

Polaris Venture Management Co. VI, L.L.C.

Large shareholder
500,000 -4.4%
6.00
USD 3,000,000
500,000 -4.4% 6.00 USD 3,000,000
2023-09-13 2023-09-11 S Sale

MCGUIRE TERRANCE

Non-Executive Director Large shareholder
500,000 -4.4%
6.00
USD 3,000,000
500,000 -4.4% 6.00 USD 3,000,000
2023-09-06 2023-09-05 S Sale

Romano Gary

Chief Medical Officer

Officer
2,771 -2.7%
5.19
USD 14,393
2,771 -2.7% 5.19 USD 14,393
2023-09-06 2023-09-05 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
6,214 -3.4%
5.19
USD 32,277
6,214 -3.4% 5.19 USD 32,277
2023-09-06 2023-09-05 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
5,647 -0.3%
5.19
USD 29,333
5,647 -0.3% 5.19 USD 29,333
2023-09-06 2023-09-05 S Sale

GRASSO MARC

Chief Financial Officer

Officer
1,114 -3.3%
5.19
USD 5,786
1,114 -3.3% 5.19 USD 5,786
2023-06-05 2023-06-02 S Sale

GRASSO MARC

Chief Financial Officer

Officer
1,050 -3.1%
6.90
USD 7,249
1,050 -3.1% 6.90 USD 7,249
2023-06-05 2023-06-02 S Sale

Romano Gary

Chief Medical Officer

Officer
2,617 -2.5%
6.90
USD 18,067
2,617 -2.5% 6.90 USD 18,067
2023-06-05 2023-06-02 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
4,092 -2.2%
6.90
USD 28,250
4,092 -2.2% 6.90 USD 28,250
2023-06-05 2023-06-02 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
5,255 -0.3%
6.90
USD 36,279
5,255 -0.3% 6.90 USD 36,279
2023-03-21 2023-03-17 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,186 -0.9%
6.22
USD 94,428
15,186 -0.9% 6.22 USD 94,428
2023-03-03 2023-03-02 S Sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
5,849 -0.4%
8.32
USD 48,651
5,849 -0.4% 8.32 USD 48,651
2023-03-03 2023-03-02 S Sale

Romano Gary

Chief Medical Officer

Officer
3,238 -3.0%
8.32
USD 26,933
3,238 -3.0% 8.32 USD 26,933
2023-03-03 2023-03-02 S Sale

GRASSO MARC

Chief Financial Officer

Officer
1,291 -3.6%
8.32
USD 10,739
1,291 -3.6% 8.32 USD 10,739
2023-03-03 2023-03-02 S Sale

Kenkare-Mitra Sara

President and Head of R&D

Officer
10,124 -5.1%
8.32
USD 84,216
10,124 -5.1% 8.32 USD 84,216
2023-03-03 2022-12-02 S Sale

Romano Gary

Chief Medical Officer

Officer
2,145 -1.9%
8.71
USD 18,679
2,145 -1.9% 8.71 USD 18,679
2022-09-07 2022-09-02 S Sale

King Robert

Chief Development Officer

Officer
176 -0.0%
10.62
USD 1,869
176 -0.0% 10.62 USD 1,869
2022-09-07 2022-09-02 S Sale

Romano Gary

Chief Medical Officer

Officer
2,177 -2.4%
10.62
USD 23,120
2,177 -2.4% 10.62 USD 23,120
2022-06-06 2022-06-02 PS Planned sale

King Robert

Chief Development Officer

Officer
177 -0.0%
8.71
USD 1,542
177 -0.0% 8.71 USD 1,542
2022-03-03 2022-03-01 S Sale

King Robert

Chief Development Officer

Officer
287 -0.1%
15.57
USD 4,468
287 -0.1% 15.57 USD 4,468
2021-12-14 2021-12-13 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
10,898 -9.6%
21.73
USD 236,802
10,898 -9.6% 21.73 USD 236,802
2021-12-14 2021-12-13 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
64,102 -36.1%
21.16
USD 1,356,347
64,102 -36.1% 21.16 USD 1,356,347
2021-12-14 2021-12-10 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
8,874 -8.0%
22.33
USD 198,192
8,874 -8.0% 22.33 USD 198,192
2021-12-14 2021-12-10 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
66,126 -37.2%
21.69
USD 1,433,975
66,126 -37.2% 21.69 USD 1,433,975
2021-12-10 2021-12-09 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
2,643 -2.5%
23.40
USD 61,858
2,643 -2.5% 23.40 USD 61,858
2021-12-10 2021-12-09 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
72,357 -40.7%
22.80
USD 1,649,986
72,357 -40.7% 22.80 USD 1,649,986
2021-12-10 2021-12-08 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
38,489 -27.3%
23.01
USD 885,690
38,489 -27.3% 23.01 USD 885,690
2021-12-10 2021-12-08 PS Planned sale

SULIMAN SHEHNAAZ

President and COO

Officer
36,511 -20.6%
22.56
USD 823,626
36,511 -20.6% 22.56 USD 823,626
2021-12-03 2021-12-01 PS Planned sale

King Robert

Chief Development Officer

Officer
250 -0.0%
20.09
USD 5,023
250 -0.0% 20.09 USD 5,023
2021-11-12 2021-11-11 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.7%
25.00
USD 1,375,000
55,000 -2.7% 25.00 USD 1,375,000
2021-11-12 2021-11-10 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.6%
25.00
USD 1,375,000
55,000 -2.6% 25.00 USD 1,375,000
2021-11-10 2021-11-09 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-10 2021-11-09 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-10 2021-11-09 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-10 2021-11-09 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.6%
25.00
USD 1,375,000
55,000 -2.6% 25.00 USD 1,375,000
2021-11-10 2021-11-08 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-10 2021-11-08 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-10 2021-11-08 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-10 2021-11-08 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.5%
25.00
USD 1,375,000
55,000 -2.5% 25.00 USD 1,375,000
2021-11-08 2021-11-05 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-08 2021-11-05 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-08 2021-11-05 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.2%
25.00
USD 375,000
15,000 -2.2% 25.00 USD 375,000
2021-11-08 2021-11-05 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.4%
25.00
USD 1,375,000
55,000 -2.4% 25.00 USD 1,375,000
2021-11-08 2021-11-04 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
USD 375,000
15,000 -2.1% 25.00 USD 375,000
2021-11-08 2021-11-04 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
USD 375,000
15,000 -2.1% 25.00 USD 375,000
2021-11-08 2021-11-04 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
15,000 -2.1%
25.00
USD 375,000
15,000 -2.1% 25.00 USD 375,000
2021-11-08 2021-11-04 PS Planned sale

Rosenthal Arnon

Chief Executive Officer

Executive Director
55,000 -2.4%
25.00
USD 1,375,000
55,000 -2.4% 25.00 USD 1,375,000
2021-07-08 2021-07-07 PS Planned sale

Paul Robert

Chief Medical Officer

Officer
17,149 -6.8%
39.32
USD 674,220
17,149 -6.8% 39.32 USD 674,220
// ... existing code ... // ... rest of the file ...